Cargando…
Innate immune recognition and modulation in hepatitis D virus infection
Hepatitis D virus (HDV) is a global health threat with more than 15 million humans affected. Current treatment options are largely unsatisfactory leaving chronically infected humans at high risk to develop liver cirrhosis and hepatocellular carcinoma. HDV is the only human satellite virus known. It...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284172/ https://www.ncbi.nlm.nih.gov/pubmed/32550754 http://dx.doi.org/10.3748/wjg.v26.i21.2781 |
_version_ | 1783544407189880832 |
---|---|
author | Jung, Stephanie Altstetter, Sebastian Maximilian Protzer, Ulrike |
author_facet | Jung, Stephanie Altstetter, Sebastian Maximilian Protzer, Ulrike |
author_sort | Jung, Stephanie |
collection | PubMed |
description | Hepatitis D virus (HDV) is a global health threat with more than 15 million humans affected. Current treatment options are largely unsatisfactory leaving chronically infected humans at high risk to develop liver cirrhosis and hepatocellular carcinoma. HDV is the only human satellite virus known. It encodes only two proteins, and requires Hepatitis B virus (HBV) envelope protein expression for productive virion release and spread of the infection. How HDV could evolve and why HBV was selected as a helper virus remains unknown. Since the discovery of Na(+)-taurocholate co-transporting polypeptide as the essential uptake receptor for HBV and HDV, we are beginning to understand the interactions of HDV and the immune system. While HBV is mostly regarded a stealth virus, that escapes innate immune recognition, HBV-HDV coinfection is characterized by a strong innate immune response. Cytoplasmic RNA sensor melanoma differentiation antigen 5 has been reported to recognize HDV RNA replication and activate innate immunity. Innate immunity, however, seems not to impair HDV replication while it inhibits HBV. In this review, we describe what is known up-to-date about the interplay between HBV as a helper and HDV’s immune evasion strategy and identify where additional research is required. |
format | Online Article Text |
id | pubmed-7284172 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-72841722020-06-17 Innate immune recognition and modulation in hepatitis D virus infection Jung, Stephanie Altstetter, Sebastian Maximilian Protzer, Ulrike World J Gastroenterol Minireviews Hepatitis D virus (HDV) is a global health threat with more than 15 million humans affected. Current treatment options are largely unsatisfactory leaving chronically infected humans at high risk to develop liver cirrhosis and hepatocellular carcinoma. HDV is the only human satellite virus known. It encodes only two proteins, and requires Hepatitis B virus (HBV) envelope protein expression for productive virion release and spread of the infection. How HDV could evolve and why HBV was selected as a helper virus remains unknown. Since the discovery of Na(+)-taurocholate co-transporting polypeptide as the essential uptake receptor for HBV and HDV, we are beginning to understand the interactions of HDV and the immune system. While HBV is mostly regarded a stealth virus, that escapes innate immune recognition, HBV-HDV coinfection is characterized by a strong innate immune response. Cytoplasmic RNA sensor melanoma differentiation antigen 5 has been reported to recognize HDV RNA replication and activate innate immunity. Innate immunity, however, seems not to impair HDV replication while it inhibits HBV. In this review, we describe what is known up-to-date about the interplay between HBV as a helper and HDV’s immune evasion strategy and identify where additional research is required. Baishideng Publishing Group Inc 2020-06-07 2020-06-07 /pmc/articles/PMC7284172/ /pubmed/32550754 http://dx.doi.org/10.3748/wjg.v26.i21.2781 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Minireviews Jung, Stephanie Altstetter, Sebastian Maximilian Protzer, Ulrike Innate immune recognition and modulation in hepatitis D virus infection |
title | Innate immune recognition and modulation in hepatitis D virus infection |
title_full | Innate immune recognition and modulation in hepatitis D virus infection |
title_fullStr | Innate immune recognition and modulation in hepatitis D virus infection |
title_full_unstemmed | Innate immune recognition and modulation in hepatitis D virus infection |
title_short | Innate immune recognition and modulation in hepatitis D virus infection |
title_sort | innate immune recognition and modulation in hepatitis d virus infection |
topic | Minireviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284172/ https://www.ncbi.nlm.nih.gov/pubmed/32550754 http://dx.doi.org/10.3748/wjg.v26.i21.2781 |
work_keys_str_mv | AT jungstephanie innateimmunerecognitionandmodulationinhepatitisdvirusinfection AT altstettersebastianmaximilian innateimmunerecognitionandmodulationinhepatitisdvirusinfection AT protzerulrike innateimmunerecognitionandmodulationinhepatitisdvirusinfection |